InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-7.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Remmel H. Lawrence, Director. Officer active across 1 company, notably Atossa Therapeutics, INC.. Cumulatively, 2 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 26 March 2025. The latest transaction was disclosed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Remmel H. Lawrence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
10,000 股0Common StockSEC:0001193125-26-224140:0
10,000 股@ US$0.70100.0% 占其流量Common StockSEC:0000950170-25-046742:0
标准退出：2025年6月24日 (T+90)
2 条申报中的 2 条
About Remmel H. Lawrence
Lawrence H. Remmel is a Director at ATOSSA THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset to the board of directors. He plays a key role in the future direction of ATOSSA.
